| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/25/2002 | WO2002057416A2 Improved biochip |
| 07/25/2002 | WO2002057415A2 Method for altering cell fate |
| 07/25/2002 | WO2002057412A2 Plant promoters, and methods of use |
| 07/25/2002 | WO2002057411A2 Hydrolase enzymes and their use in kinetic resolution |
| 07/25/2002 | WO2002057409A2 Antisense modulation of src-2 expression |
| 07/25/2002 | WO2002057408A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 07/25/2002 | WO2002057407A2 Novel method for transgenic plants by transformation & regeneration of indica rice plant shoot tips |
| 07/25/2002 | WO2002057406A2 Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops |
| 07/25/2002 | WO2002057315A2 Streptococcal streptolysin s vaccines |
| 07/25/2002 | WO2002057314A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | WO2002057311A2 Sphingosine 1-phosphate receptor gene, sppr |
| 07/25/2002 | WO2002057310A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 07/25/2002 | WO2002057307A2 Genes |
| 07/25/2002 | WO2002057305A2 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages |
| 07/25/2002 | WO2002057304A2 Secretory molecules |
| 07/25/2002 | WO2002057303A2 Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002057301A2 Gene silencing suppressor |
| 07/25/2002 | WO2002057300A1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 07/25/2002 | WO2002057294A2 Zinc finger proteins for dna binding and gene regulation in plants |
| 07/25/2002 | WO2002057293A2 Modified zinc finger binding proteins |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002057289A1 Reagent for the isolation of rna |
| 07/25/2002 | WO2002057226A2 68730 and 69112 protein kinase molecules and uses therefor |
| 07/25/2002 | WO2002056918A2 Method of enhancing delivery of a therapeutic nucleic acid |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056900A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 07/25/2002 | WO2002056837A2 Inhibition of protein-phosphatases for the treatment of heart failure |
| 07/25/2002 | WO2002056828A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/25/2002 | WO2002056668A2 Methods to control the host range of retroviral vectors |
| 07/25/2002 | WO2002040511A9 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 07/25/2002 | WO2002038589A3 Haplotypes of the cyp2d6 gene |
| 07/25/2002 | WO2002036756A3 Lactobacillus strain, and plasmid hosted by same |
| 07/25/2002 | WO2002034935A8 In vitro selection of signaling aptamers |
| 07/25/2002 | WO2002033085A9 Wisp polypeptides and therapeutical applications thereof |
| 07/25/2002 | WO2002031112A3 Enhanced transformation and regeneration of transformed embryogenic pine tissue |
| 07/25/2002 | WO2002030256A3 Diagnostic indicator of thymic function |
| 07/25/2002 | WO2002029028A3 Brassicaceae with altered floral development |
| 07/25/2002 | WO2002028439A3 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 07/25/2002 | WO2002027002B1 Method for generating or increasing resistance to biotic or abiotic stress factors in organisms |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002020804B1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002019968A9 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
| 07/25/2002 | WO2002018537A3 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 07/25/2002 | WO2002016577A3 Enhanced recovery of transformed cells |
| 07/25/2002 | WO2002016564A3 Novel human proteases and polynucleotides encoding the same |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002013765A3 Malaria immunogen and vaccine |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002008448A3 Non-viral linear dna vectors and methods for using the same |
| 07/25/2002 | WO2002006463A3 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002004496A3 Fimh adhesin proteins and methods of use |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2002000894A3 Gene silencing vector |
| 07/25/2002 | WO2002000857A3 53320, a human acyltransferase and uses therefor |
| 07/25/2002 | WO2001096371A3 Adipose-related gene |
| 07/25/2002 | WO2001095701A3 Methods for somatic embryo formation and plant regeneration of beta vulgaris |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001088160A3 Vectors for dna delivery |
| 07/25/2002 | WO2001088126A3 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 07/25/2002 | WO2001085940A3 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 07/25/2002 | WO2001077332A3 Compositions and methods related to canine igg and canine il-13 receptors |
| 07/25/2002 | WO2001075093A8 Novel nucleic acids and polypeptides |
| 07/25/2002 | WO2001074346A3 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001066750A3 G protein-coupled receptors |
| 07/25/2002 | WO2001066721A3 Nucleic acid sensor molecules |
| 07/25/2002 | WO2001066565A3 In vivo production of cyclic peptides |
| 07/25/2002 | WO2001064904A3 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 07/25/2002 | WO2001062929A3 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 07/25/2002 | WO2001060992A3 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 07/25/2002 | WO2001059092A3 Methods for generating hypermutable bacteria |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001053533A3 Method for cloning polyketide synthase genes |
| 07/25/2002 | WO2001042297A9 Clasp-3 transmembrane protein |
| 07/25/2002 | WO2001033945A8 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 07/25/2002 | WO2001032854A8 Production of transgenic animals using nuclear transfer and oocytes recovered by lopu |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | WO2001030812A9 Activation of hcv-specific t cells |
| 07/25/2002 | WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001004613A9 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 07/25/2002 | WO2001003730A9 Unmarked deletion mutants of mycobacteria and methods of using same |
| 07/25/2002 | WO2001002574A9 Negative regulators of systemic acquired resistance |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001002559A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | WO2001000642A9 High affinity, low molecular weight displacers for oligonucleotide purification |
| 07/25/2002 | WO2000056901A9 Linear and circular expression elements |